Erin Gull | Investor Relations |
A. J. Kazimi | Chief Executive Officer |
Marty Cearnal | Chief Commercial Officer |
Michael Bonner | Chief Financial Officer |
Andrew D'Silva | B. Riley FBR |
Thank you for joining the Cumberland Pharmaceuticals’ Fourth Quarter 2019 Financial Report and Company Update. Please note that this conference call is being recorded at the company’s request and will be archived on Cumberland’s website for 1 week from today’s date.
Now, I would like to introduce Erin Gull, who is responsible for Corporate Relations at Cumberland. Erin, please go ahead.
Good afternoon.